FDA rejects 'Neffy,' nasal spray alternative to EpiPen, company says

  • 📰 abc7newsbayarea
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 51%

United Kingdom News News

United Kingdom United Kingdom Latest News,United Kingdom United Kingdom Headlines

Neffy is inhaled and would have been available by prescription if approved.

About 40 million people in the US experience extreme allergic reactions. If approved, Neffy would be the first needle-free nasal spray epinephrine treatment for people with severeRegulators at the U.S. Food and Drug Administration declined to approve a needle-free nasal spray equivalent to an EpiPen, pending further study, according to the company developing it.

ARS Pharma developed the product, Neffy, which is inhaled and would have been available by prescription if approved. Neffy would be a first-of-its-kind alternative to an EpiPen, which is commonly used to treat anaphylaxis, or severe allegoric reactions. The FDA said they haven't yet seen enough evidence to support approval. The company will have an opportunity to run additional studies and apply for approval again.

'We are very surprised by this action and the late requirement at this time to change the repeat-dose study from a post-marketing requirement, which we had previously aligned on with FDA, to a pre-approval requirement, particularly given the positive Advisory Committee vote," Richard Lowenthal, CEO of ARS, said in

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 529. in UK
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

United Kingdom United Kingdom Latest News, United Kingdom United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA rejects 'Neffy,' nasal spray alternative to EpiPen, company saysNeffy is inhaled and would have been available by prescription if approved.
Source: abc13houston - 🏆 255. / 63 Read more »

FDA rejects 'Neffy,' nasal spray alternative to EpiPen, company saysNeffy is inhaled and would have been available by prescription if approved.
Source: ABC7NY - 🏆 592. / 51 Read more »

FDA rejects 'Neffy,' nasal spray alternative to EpiPen, company saysNeffy is inhaled and would have been available by prescription if approved.
Source: ABC7 - 🏆 67. / 68 Read more »

FDA rejects 'Neffy,' nasal spray alternative to EpiPen, company saysNeffy is inhaled and would have been available by prescription if approved.
Source: ABC7Chicago - 🏆 284. / 63 Read more »